Ingevity Affirms FY Guidance Of Sales $1.40B-$1.50B; Adj. EBITDA $350M-360M
Portfolio Pulse from Benzinga Newsdesk
Ingevity has reaffirmed its full-year guidance, projecting sales between $1.40 billion and $1.50 billion, and adjusted EBITDA between $350 million and $360 million.
October 29, 2024 | 8:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ingevity has reaffirmed its full-year guidance, projecting sales between $1.40 billion and $1.50 billion, and adjusted EBITDA between $350 million and $360 million. This indicates stability and confidence in their financial performance.
The reaffirmation of guidance suggests that Ingevity is on track to meet its financial targets, which is a positive signal for investors. This stability can lead to increased investor confidence and potentially a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100